• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group.

作者信息

Cseh Annamaria, Niemeyer Charlotte M, Yoshimi Ayami, Dworzak Michael, Hasle Henrik, van den Heuvel-Eibrink Marry M, Locatelli Franco, Masetti Riccardo, Schmugge Markus, Groß-Wieltsch Ute, Candás Andrea, Kulozik Andreas E, Olcay Lale, Suttorp Meinolf, Furlan Ingrid, Strahm Brigitte, Flotho Christian

机构信息

Division of Pediatric Hematology-Oncology, Department of Pediatrics and Adolescent Medicine, University Medical Center, Freiburg, Germany.

Division of Pediatric Hematology-Oncology, Department of Pediatrics and Adolescent Medicine, University Medical Center, Freiburg, Germany German Cancer Consortium (DKTK), Heidelberg, Germany.

出版信息

Blood. 2015 Apr 2;125(14):2311-3. doi: 10.1182/blood-2015-01-619734.

DOI:10.1182/blood-2015-01-619734
PMID:25838281
Abstract
摘要

相似文献

1
Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group.阿扎胞苷用于青少年骨髓单核细胞白血病过渡至移植治疗：EWOG-MDS研究组的回顾性分析
Blood. 2015 Apr 2;125(14):2311-3. doi: 10.1182/blood-2015-01-619734.
2
Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7.一名患有青少年粒单核细胞白血病和7号染色体单体的患者对阿扎胞苷产生的有趣反应。
Blood. 2009 Mar 19;113(12):2867-8. doi: 10.1182/blood-2008-12-195693.
3
Sustained remission with azacitidine monotherapy and an aberrant precursor B-lymphoblast population in juvenile myelomonocytic leukemia.阿扎胞苷单药治疗伴幼稚前体细胞异常的幼年髓单核细胞白血病的持续缓解。
Pediatr Blood Cancer. 2019 Oct;66(10):e27905. doi: 10.1002/pbc.27905. Epub 2019 Jun 28.
4
Azacitidine as a bridge to transplantation in juvenile myelomonocytic leukemia.阿扎胞苷作为青少年骨髓单核细胞白血病移植的桥梁。
Pediatr Int. 2022 Jan;64(1):e14929. doi: 10.1111/ped.14929.
5
DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia.DNA 低甲基化剂作为骨髓增生异常综合征和幼年型粒单核细胞白血病异基因造血干细胞移植前后的表观遗传学治疗。
Semin Cancer Biol. 2018 Aug;51:68-79. doi: 10.1016/j.semcancer.2017.10.011. Epub 2017 Nov 9.
6
A retrospective analysis of azacitidine treatment for juvenile myelomonocytic leukemia.回顾性分析阿扎胞苷治疗幼年骨髓单核细胞白血病。
Int J Hematol. 2022 Feb;115(2):263-268. doi: 10.1007/s12185-021-03248-x. Epub 2021 Oct 29.
7
Molecular assessment of pretransplant chemotherapy in the treatment of juvenile myelomonocytic leukemia.移植前化疗治疗幼年骨髓单核细胞白血病的分子评估。
Pediatr Blood Cancer. 2019 Nov;66(11):e27948. doi: 10.1002/pbc.27948. Epub 2019 Jul 26.
8
Azacitidine (Vidaza) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015).阿扎胞苷（Vidaza）治疗复发性高级 MDS 和 JMML 儿科患者：ITCC 联盟和 EWOG-MDS 组的 I/II 期研究结果（研究 ITCC-015）。
Paediatr Drugs. 2023 Nov;25(6):719-728. doi: 10.1007/s40272-023-00588-5. Epub 2023 Sep 11.
9
Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study group.低剂量阿扎胞苷治疗儿童和年轻成人骨髓增生异常综合征：EWOG-MDS研究组的回顾性分析
Br J Haematol. 2016 Mar;172(6):930-6. doi: 10.1111/bjh.13915. Epub 2016 Jan 13.
10
Real Life Data on Efficacy and Safety of Azacitidine Therapy for Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia.真实世界中阿扎胞苷治疗骨髓增生异常综合征、慢性粒单核细胞白血病和急性髓系白血病的疗效和安全性数据。
Pathol Oncol Res. 2019 Jul;25(3):1175-1180. doi: 10.1007/s12253-018-00574-0. Epub 2019 Jan 6.

引用本文的文献

1
Azacytidine Monotherapy in an Infant With Mosaic NRAS-Driven Juvenile Myelomonocytic Leukemia.阿扎胞苷单药治疗1例由嵌合型NRAS驱动的幼年型粒单核细胞白血病婴儿
Pediatr Blood Cancer. 2025 May;72(5):e31647. doi: 10.1002/pbc.31647. Epub 2025 Mar 4.
2
Observation and Management of Juvenile Myelomonocytic Leukemia and Noonan Syndrome-Associated Myeloproliferative Disorder: A Real-World Experience.青少年骨髓单核细胞白血病及努南综合征相关骨髓增殖性疾病的观察与管理：一项真实世界经验
Cancers (Basel). 2024 Aug 2;16(15):2749. doi: 10.3390/cancers16152749.
3
Azacitidine (Vidaza) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015).
阿扎胞苷（Vidaza）治疗复发性高级 MDS 和 JMML 儿科患者：ITCC 联盟和 EWOG-MDS 组的 I/II 期研究结果（研究 ITCC-015）。
Paediatr Drugs. 2023 Nov;25(6):719-728. doi: 10.1007/s40272-023-00588-5. Epub 2023 Sep 11.
4
Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft.第二次异基因干细胞移植可挽救相当一部分在首次同种异体移植后复发的幼年型粒单核细胞白血病患者。
Bone Marrow Transplant. 2023 May;58(5):607-609. doi: 10.1038/s41409-023-01942-4. Epub 2023 Feb 23.
5
Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemia.阿扎胞苷和 MEK 抑制剂联合治疗在 PTPN11 突变型幼年骨髓单核细胞白血病中的潜在临床应用。
Mol Ther. 2023 Apr 5;31(4):986-1001. doi: 10.1016/j.ymthe.2023.01.030. Epub 2023 Feb 3.
6
Juvenile Myelomonocytic Leukemia in a Child: A Case Report of Palliative Chemotherapy and Literature Review Applied to Limited Resources Centers.儿童青少年骨髓单核细胞白血病：姑息化疗病例报告及适用于资源有限中心的文献综述
Case Rep Hematol. 2022 Nov 16;2022:1185140. doi: 10.1155/2022/1185140. eCollection 2022.
7
Genomic and Epigenomic Landscape of Juvenile Myelomonocytic Leukemia.青少年粒单核细胞白血病的基因组和表观基因组图谱
Cancers (Basel). 2022 Mar 4;14(5):1335. doi: 10.3390/cancers14051335.
8
Induced Pluripotent Stem Cells to Model Juvenile Myelomonocytic Leukemia: New Perspectives for Preclinical Research.诱导多能干细胞模型的幼年髓单核细胞白血病：临床前研究的新视角。
Cells. 2021 Sep 6;10(9):2335. doi: 10.3390/cells10092335.
9
Juvenile myelomonocytic leukemia in the molecular era: a clinician's guide to diagnosis, risk stratification, and treatment.分子时代的青少年骨髓单核细胞白血病：诊断、风险分层和治疗的临床医生指南。
Blood Adv. 2021 Nov 23;5(22):4783-4793. doi: 10.1182/bloodadvances.2021005117.
10
Current Treatment of Juvenile Myelomonocytic Leukemia.青少年骨髓单核细胞白血病的当前治疗方法
J Clin Med. 2021 Jul 13;10(14):3084. doi: 10.3390/jcm10143084.